Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06348108 · RECRUITING
Trial details
- NCT number
- NCT06348108
- Sponsor
- Alfred Chung, MD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2027-07-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.